ATYR logo

aTyr Pharma (ATYR) Company Overview

Profile

Full Name:

aTyr Pharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Description:

aTyr Pharma is a biotechnology company focused on developing innovative therapies for rare diseases. They use their expertise in protein biology to create treatments that target specific pathways in the immune system, aiming to improve the lives of patients with serious health conditions.

Key Details

Price

$3.43

Annual Revenue

$353.00 K(-96.60% YoY)

Annual EPS

-$0.94(+41.25% YoY)

Annual ROE

-62.30%

Beta

1.04

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 1, 2019

Analyst ratings

Recent major analysts updates

Feb 18, 25 Leerink Partners
Outperform
Jan 6, 25 Cantor Fitzgerald
Overweight
Dec 10, 24 HC Wainwright & Co.
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Oct 29, 24 HC Wainwright & Co.
Buy
Oct 4, 24 Wells Fargo
Overweight
Sep 5, 24 Jefferies
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 14, 24 RBC Capital
Outperform
Aug 1, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for aTyr Pharma?
  • Does aTyr Pharma pay dividends?
  • What sector is aTyr Pharma in?
  • What industry is aTyr Pharma in?
  • What country is aTyr Pharma based in?
  • Is aTyr Pharma in the S&P 500?
  • Is aTyr Pharma in the NASDAQ 100?
  • Is aTyr Pharma in the Dow Jones?
  • When was aTyr Pharma's last earnings report?
  • When does aTyr Pharma report earnings?
  • Should I buy aTyr Pharma stock now?

What is the ticker symbol for aTyr Pharma?

The ticker symbol for aTyr Pharma is NASDAQ:ATYR

Does aTyr Pharma pay dividends?

No, aTyr Pharma does not pay dividends

What sector is aTyr Pharma in?

aTyr Pharma is in the Healthcare sector

What industry is aTyr Pharma in?

aTyr Pharma is in the Biotechnology industry

What country is aTyr Pharma based in?

aTyr Pharma is headquartered in United States

Is aTyr Pharma in the S&P 500?

No, aTyr Pharma is not included in the S&P 500 index

Is aTyr Pharma in the NASDAQ 100?

No, aTyr Pharma is not included in the NASDAQ 100 index

Is aTyr Pharma in the Dow Jones?

No, aTyr Pharma is not included in the Dow Jones index

When was aTyr Pharma's last earnings report?

aTyr Pharma's most recent earnings report was on Nov 7, 2024

When does aTyr Pharma report earnings?

The next expected earnings date for aTyr Pharma is Mar 13, 2025

Should I buy aTyr Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions